Literature DB >> 22373901

[Comorbidities and psoriasis. Impact on clinical practice].

S Gerdes1, U Mrowietz.   

Abstract

Psoriasis is a genetically determined, chronic inflammatory systemic disease. Besides skin symptoms, patients with moderate to severe forms of psoriasis show an association with other diseases, referred to as comorbidities. Metabolic disorders (e.g. diabetes mellitus, insulin resistance, dyslipidemia mainly in obese patients) and cardiovascular diseases (e.g. arterial hypertension, coronary artery disease, myocardial infarction and stroke) are of importance as they can increase patients' mortality. In addition, psychiatric diseases are more frequent in psoriasis patients and influence the therapeutic approach. The dermatologist in most cases is the primarily consulted physician for patients with psoriasis and therefore plays the role as a gatekeeper managing therapy. He is responsible for the early diagnosis of comorbidities and insuring their appropriate management. The anti-psoriatic treatment has to be adapted to existing comorbidities and their systemic treatments. The following article provides information on psoriatic comorbidities and their consequences for daily practice.

Entities:  

Mesh:

Year:  2012        PMID: 22373901     DOI: 10.1007/s00105-011-2230-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  45 in total

Review 1.  Obesity and psoriasis: body weight and body mass index influence the response to biological treatment.

Authors:  L Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-04-15       Impact factor: 6.166

2.  Relationship between smoking and the clinical severity of psoriasis.

Authors:  Cristina Fortes; Simona Mastroeni; Karen Leffondré; Francesca Sampogna; Franco Melchi; Eva Mazzotti; Paolo Pasquini; Damiano Abeni
Journal:  Arch Dermatol       Date:  2005-12

Review 3.  The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know.

Authors:  Swati Kannan; Misha M Heller; Eric S Lee; John Ym Koo
Journal:  J Dermatolog Treat       Date:  2011-09-30       Impact factor: 3.359

Review 4.  Adipokines and psoriasis.

Authors:  Sascha Gerdes; Martin Rostami-Yazdi; Ulrich Mrowietz
Journal:  Exp Dermatol       Date:  2011-02       Impact factor: 3.960

5.  Gastric bypass surgery improves psoriasis.

Authors:  Eric W Hossler; Michele S Maroon; Chris M Mowad
Journal:  J Am Acad Dermatol       Date:  2010-07-22       Impact factor: 11.527

6.  Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress.

Authors:  M A McAleer; D L Mason; S Cunningham; S J O'Shea; P A McCormick; C Stone; P Collins; S Rogers; B Kirby
Journal:  Br J Dermatol       Date:  2011-06       Impact factor: 9.302

7.  Attributable risk estimate of severe psoriasis on major cardiovascular events.

Authors:  Nehal N Mehta; YiDing Yu; Rebecca Pinnelas; Parasuram Krishnamoorthy; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

8.  Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population.

Authors:  Yongtang Jin; Fengyu Zhang; Sen Yang; Yunming Kong; Fengli Xiao; Yong Hou; Xing Fan; Xuejun Zhang
Journal:  J Dermatol Sci       Date:  2008-06-27       Impact factor: 4.563

9.  Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China.

Authors:  Y Jin; S Yang; F Zhang; Y Kong; F Xiao; Y Hou; X Fan; X Zhang
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-08-13       Impact factor: 6.166

10.  Psoriasis patients show signs of insulin resistance.

Authors:  S Boehncke; D Thaci; H Beschmann; R J Ludwig; H Ackermann; K Badenhoop; W-H Boehncke
Journal:  Br J Dermatol       Date:  2007-10-04       Impact factor: 9.302

View more
  4 in total

1.  [Does the risk of cardiovascular complications decrease in psoriatic patients receiving systemic therapy?].

Authors:  R Gläser; S Gerdes
Journal:  Hautarzt       Date:  2013-01       Impact factor: 0.751

2.  [Depression and anxiety disorders among psoriasis patients: protective and exacerbating factors].

Authors:  K Bangemann; W Schulz; J Wohlleben; A Weyergraf; I Snitjer; T Werfel; G Schmid-Ott; D Böhm
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

3.  Psoriasis and psychiatric morbidity: a profile from a tertiary care centre of eastern India.

Authors:  Somenath Sarkar; Arnab Sarkar; Revanta Saha; Tanusree Sarkar
Journal:  J Family Med Prim Care       Date:  2014-01

4.  Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls.

Authors:  Nádia Couto Bavoso; Jackson Machado Pinto; Maria Marta Sarquis Soares; Michelle Dos Santos Diniz; Antônio Lúcio Teixeira Júnior
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.